Volume : 09, Issue : 12, December – 2022
Title:
27.ENHANCEMENT OF SOLUBILITY AND FORMULATION OF FAST DISSOLVING SUBLINGUAL WAFERS OF FLURBIPROFEN FOR EFFECTIVE TREATMENT OF DENTAL PAIN
Authors :
Deepak, Dr. Vivek Gupta*
Abstract :
The enhancement of dissolution rate and oral bioavailability of poorly soluble drugs remains one of the most challenging aspects of the drug development. Among the different methods of dissolution enhancement, Solid dispersion technology was found to be more successful with number of drugs. Solid dispersion of Flurbiprofen with PVP K-90 by physical mixture method were prepared. Further fast dissolving oral film of Flurbiprofen were conveniently formulated by solvent casting method. The In vitro dissolution studies showed that Flurbiprofen fast dissolving films formulation F3 showed maximum 98.78±0.25% over a period of 15min. Overall the results of the dissolution rate studies indicated greater dissolution rate of Flurbiprofen from fast dissolving oral film. Fast dissolving oral film containing Flurbiprofen were prepared using solvent casting method. Total six formulations were prepared using varying amount of Sodium Starch glycolate and Croscarmellose sodium. The prepared films were further evaluated for Thickness, Uniformity of Weight, Folding endurance, Disintegrating time, Tensile strength, Percentage Moisture Content, % Assay and In-vitro Release Studies. Percentage assay of different formulation was determined by UV-Vis Spectroscopy. The percentage assay of different formulation was in range of 97.14±0.41 to 99.45±0.36%.
Cite This Article:
Please cite this article in press Vivek Gupta et al, Enhancement Of Solubility And Formulation Of Fast Dissolving Sublingual Wafers Of Flurbiprofen For Effective Treatment Of Dental Pain.., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
2. Upendra C Galgatte*, Pooja P Patil and Pravin D Chaudhari, Development of Fast Dissolving Sublingual Wafers by Using Film Former: Optimization and Characterization, Journal of Chemical and Pharmaceutical Research, 2017, 9(4):82-91
3. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008 Feb;4(1):269-86. doi: 10.2147/tcrm.s1458. PMID: 18728716; PMCID: PMC2503662.
4. Tekade AR, Yadav JN. A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs. Adv Pharm Bull. 2020 Jul;10(3):359-369. doi: 10.34172/apb.2020.044. Epub 2020 May 11.
5. Paramita Dey, Arnabi Ghosh, Wafers: An innovative Advancement of oro-dispersible Films, Int J App Pharm, Vol 8, Issue 1, 2016, 1-7.
6. Nair SS, Padamanabhan R, Sreena K. Development and Evaluation of fast dissolving oral thin film containing prochlorperazine maleate. Eur. J. Pharm. Medical Res. 2016; 3(1):379-84.
7. Nagesh G, Santosh J, Audumbar M, Manojkumar P. A review on recent trends in oral drug delivery-lyophilized wafer technology. Int J Res Pharm and Pharm Sci. 2016;1:5-9.
8. Deepthi A, Reddy BV, Navaneetha K. Formulation and evaluation of fast dissolving oral films of zolmitriptan. American journal of advanced drug delivery. 2014; 2(2):153-63.
9. Vaidya MM, Khutle NM, Gide PS. Oral fast dissolving drug delivery system: A modern approach for patient compliance. World J Pharm Res. 2013 Mar 2; 2(3):558-77.
10. Yamashita K, Fukusaki M, Ando Y, Fujinaga A, Tanabe T, Terao Y, Sumikawa K. Preoperative administration of intravenous flurbiprofen axetil reduces postoperative pain for spinal fusion surgery. Journal of Anesthesia. 2006 May; 20(2):92-5.
11. Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE. NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo. The Journal of clinical investigation. 2003 Aug 1; 112(3):440-9.